fenoxanil
Names
[ CAS No. ]:
115852-48-7
[ Name ]:
fenoxanil
[Synonym ]:
(2R)-N-[(2Ξ)-2-cyano-3-methylbutan-2-yl]-2-(2,4-dichlorophenoxy)propanamide
Propanamide, N-(1-cyano-1,2-dimethylpropyl)-2-(2,4-dichlorophenoxy)-
(RS)-N-[(RS)-1-cyano-1,2-dimethylpropyl]-2-(2,4-dichlorophenoxy)propionamide
Fenoxanil
N-(1-Cyano-1,2-dimethylpropyl)-2-(2,4-dichlorophenoxy)propanamide
N-(2-Cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide
N-(2-Cyan-3-methylbutan-2-yl)-2-(2,4-dichlorphenoxy)propanamid
MFCD06798290
N-(2-Cyano-3-methyl-2-butanyl)-2-(2,4-dichlorophenoxy)propanamide
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
504.9±50.0 °C at 760 mmHg
[ Molecular Formula ]:
C15H18Cl2N2O2
[ Molecular Weight ]:
329.222
[ Flash Point ]:
259.2±30.1 °C
[ Exact Mass ]:
328.074524
[ PSA ]:
62.12000
[ LogP ]:
3.86
[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C
[ Index of Refraction ]:
1.530
[ Storage condition ]:
0-6°C
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
R36/37/38:Irritating to eyes, respiratory system and skin .
[ Safety Phrases ]:
S26-S36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
AJ2400000
[ HS Code ]:
2926909038
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2926909038
[ Summary ]:
HS: 2926909038 fenoxanil Educational tariff:17.0% Tax rebate rate:9.0% Regulatory conditions:S(Registration certificate of import and export) Lowest tariff:6.5% General tariff:30.0%
Articles
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 989 , 11-20, (2015)
A modified quick, easy, cheap, effective, rugged, and safe (QuEChERS) method using multi-walled carbon nanotubes (MWCNTs) as a reversed-dispersive solid phase extraction (r-dSPE) material combined wit...
Melanin is an essential component for the integrity of the cell wall of Aspergillus fumigatus conidia.BMC Microbiol. 9 , 177, (2009)
Aspergillus fumigatus is the most common agent of invasive aspergillosis, a feared complication in severely immunocompromised patients. Despite the recent commercialisation of new antifungal drugs, th...